Pacira BioSciences Inc (PCRX)
26.33
+0.83
(+3.25%)
USD |
NASDAQ |
Apr 26, 16:00
26.35
+0.02
(+0.08%)
After-Hours: 20:00
Pacira BioSciences Gross Profit (TTM): 490.31M for Dec. 31, 2023
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 490.31M |
September 30, 2023 | 466.80M |
June 30, 2023 | 459.41M |
March 31, 2023 | 456.93M |
December 31, 2022 | 467.53M |
September 30, 2022 | 477.68M |
June 30, 2022 | 453.96M |
March 31, 2022 | 435.52M |
December 31, 2021 | 401.28M |
September 30, 2021 | 376.77M |
June 30, 2021 | 371.19M |
March 31, 2021 | 324.05M |
December 31, 2020 | 312.32M |
September 30, 2020 | 307.16M |
June 30, 2020 | 302.05M |
March 31, 2020 | 326.26M |
December 31, 2019 | 314.32M |
September 30, 2019 | 294.93M |
June 30, 2019 | 276.93M |
March 31, 2019 | 262.72M |
December 31, 2018 | 250.43M |
September 30, 2018 | 237.08M |
June 30, 2018 | 221.80M |
March 31, 2018 | 205.74M |
December 31, 2017 | 198.72M |
Date | Value |
---|---|
September 30, 2017 | 190.21M |
June 30, 2017 | 166.31M |
March 31, 2017 | 165.77M |
December 31, 2016 | 166.27M |
September 30, 2016 | 166.88M |
June 30, 2016 | 187.99M |
March 31, 2016 | 181.62M |
December 31, 2015 | 177.16M |
September 30, 2015 | 170.09M |
June 30, 2015 | 155.44M |
March 31, 2015 | 142.43M |
December 31, 2014 | 120.23M |
September 30, 2014 | 92.59M |
June 30, 2014 | 69.40M |
March 31, 2014 | 49.12M |
December 31, 2013 | 30.78M |
September 30, 2013 | 16.37M |
June 30, 2013 | 7.10M |
March 31, 2013 | 5.832M |
December 31, 2012 | 6.945M |
September 30, 2012 | 3.799M |
June 30, 2012 | 5.199M |
March 31, 2012 | 0.061M |
December 31, 2011 | -1.052M |
September 30, 2011 | 1.399M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
276.93M
Minimum
Jun 2019
490.31M
Maximum
Dec 2023
385.02M
Average
376.77M
Median
Sep 2021
Gross Profit (TTM) Benchmarks
Dynavax Technologies Corp | 182.12M |
Arbutus Biopharma Corp | -- |
Chimerix Inc | 0.324M |
Karyopharm Therapeutics Inc | 141.09M |
FibroGen Inc | 128.90M |